Search Results - "Rudnicki, Stacy A"

Neurologic complications of gastric bypass surgery for morbid obesity by JUHASZ-POCSINE, Katalin, RUDNICKI, Stacy A, ARCHER, Robert L, HARIK, Sami I

“…The number of bariatric procedures is rapidly growing as the prevalence of obesity in the USA is increasing. Such procedures are not without complications, and…”
Get full text

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III by Kaufmann, Petra, Thompson, John L.P., Levy, Gilberto, Buchsbaum, Richard, Shefner, Jeremy, Krivickas, Lisa S., Katz, Jonathan, Rollins, Yvonne, Barohn, Richard J., Jackson, Carlayne E., Tiryaki, Ezgi, Lomen-Hoerth, Catherine, Armon, Carmel, Tandan, Rup, Rudnicki, Stacy A., Rezania, Kourosh, Sufit, Robert, Pestronk, Alan, Novella, Steven P., Heiman-Patterson, Terry, Kasarskis, Edward J., Pioro, Erik P., Montes, Jacqueline, Arbing, Rachel, Vecchio, Darleen, Barsdorf, Alexandra, Mitsumoto, Hiroshi, Levin, Bruce

“…Objective Amyotrophic lateral sclerosis (ALS) is a devastating, and currently incurable, neuromuscular disease in which oxidative stress and mitochondrial…”
Get full text

ALS and Frontotemporal Dysfunction: A Review by Achi, Eugene Y., Rudnicki, Stacy A.

“…Though once believed to be a disease that was limited to the motor system, it is now apparent that amyotrophic lateral sclerosis (ALS) may be associated with…”
Get full text

A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS by Bozik, Michael E., Mitsumoto, Hiroshi, Brooks, Benjamin R., Rudnicki, Stacy A., Moore, Dan H., Zhang, Bing, Ludolph, Albert, Cudkowicz, Merit E., van den Berg, Leonard H., Mather, James, Petzinger, Thomas, Archibald, Donald

“…Abstract Our objective was to compare the phase II and phase III (EMPOWER) studies of dexpramipexole in ALS and evaluate potential EMPOWER responder subgroups…”
Get full text

Editorial to the supplement entitled "assessments of pulmonary function in patients with amyotrophic lateral sclerosis: options and applicability in both the clinical care and clinical trial settings" by Rudnicki, Stacy A.

Get full text

Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis by Andrews, Jinsy A, Meng, Lisa, Kulke, Sarah F, Rudnicki, Stacy A, Wolff, Andrew A, Bozik, Michael E, Malik, Fady I, Shefner, Jeremy M

“…The prognostic value of slow vital capacity (SVC) in relation to respiratory function decline and disease progression in patients with amyotrophic lateral…”
Get more information

Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey by Gebrehiwet, Paulos, Brekke, Johan, Rudnicki, Stacy A, Mellor, Jennifer, Wright, Jack, Earl, Lucy, Ball, Nathan, Iqbal, Halima, Thomas, Owen, Castellano, Giorgio

“…To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defined milestones, overall and according to ALS progression…”
Get full text

Plasma neurofilament analysis in VITALITY-ALS by Simkins, Tyrell J., Kupfer, Stuart, Malik, Fady I., Meng, Lisa, Rudnicki, Stacy A., Wei, Jenny, Shefner, Jeremy M., Bowser, Robert

“…Objective: To evaluate correlations between neurofilament (Nf) concentrations and clinical characteristics and disease progression using a large longitudinal…”
Get full text

Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study by Rudnicki, Stacy A., Andrews, Jinsy A., Duong, Tina, Cockroft, Bettina M., Malik, Fady I., Meng, Lisa, Wei, Jenny, Wolff, Andrew A., Genge, Angela, Johnson, Nicholas E., Tesi-Rocha, Carolina, Connolly, Anne M., Darras, Basil T., Felice, Kevin, Finkel, Richard S., Shieh, Perry B., Mah, Jean K., Statland, Jeffrey, Campbell, Craig, Habib, Ali A., Kuntz, Nancy L., Oskoui, Maryam, Day, John W.

“…This phase 2, double-blind, placebo-controlled, hypothesis-generating study evaluated the effects of oral reldesemtiv , a fast skeletal muscle troponin…”
Get full text

Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial by Shefner, Jeremy M, Jacobsen, Bill, Kupfer, Stuart, Malik, Fady I, Meng, Lisa, Wei, Jenny, Wolff, Andrew A, Rudnicki, Stacy A

“…To assess the relationship among measurements of strength, function, and quality of life in an amyotrophic lateral sclerosis (ALS) clinical trial. In the…”
Get full text

A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS by Shefner, Jeremy M., Andrews, Jinsy A., Genge, Angela, Jackson, Carlayne, Lechtzin, Noah, Miller, Timothy M., Cockroft, Bettina M., Meng, Lisa, Wei, Jenny, Wolff, Andrew A., Malik, Fady I., Bodkin, Cynthia, Brooks, Benjamin R., Caress, James, Dionne, Annie, Fee, Dominic, Goutman, Stephen A., Goyal, Namita A., Hardiman, Orla, Hayat, Ghazala, Heiman-Patterson, Terry, Heitzman, Daragh, Henderson, Robert D., Johnston, Wendy, Karam, Chafic, Kiernan, Matthew C., Kolb, Stephen J., Korngut, Lawrence, Ladha, Shafeeq, Matte, Genevieve, Mora, Jesus S., Needham, Merrilee, Oskarsson, Bjorn, Pattee, Gary L., Pioro, Erik P., Pulley, Michael, Quan, Dianna, Rezania, Kourosh, Schellenberg, Kerri L., Schultz, David, Shoesmith, Christen, Simmons, Zachary, Statland, Jeffrey, Sultan, Shumaila, Swenson, Andrea, Berg, Leonard H. Van Den, Vu, Tuan, Vucic, Steve, Weiss, Michael, Whyte-Rayson, Ashley, Wymer, James, Zinman, Lorne, Rudnicki, Stacy A.

“…To evaluate safety, dose response, and preliminary efficacy of reldesemtiv over 12 weeks in patients with amyotrophic lateral sclerosis (ALS). Methods:…”
Get full text

MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial by Gebrehiwet, Paulos, Meng, Lisa, Rudnicki, Stacy A., Sarocco, Phil, Wei, Jenny, Wolff, Andrew A., Chiò, Adriano, Andrews, Jinsy A., Genge, Angela, Jackson, Carlayne E., Lechtzin, Noah, Miller, Timothy M., Shefner, Jeremy M.

“…To evaluate the Milano-Torino staging (MiToS) and King's staging systems as potential outcome measures for clinical trials in amyotrophic lateral sclerosis…”
Get full text

Understanding the use of NIV in ALS: results of an international ALS specialist survey by Heiman-Patterson, Terry D., Cudkowicz, Merit E., De Carvalho, Mamede, Genge, Angela, Hardiman, Orla, Jackson, Carlayne E., Lechtzin, Noah, Mitsumoto, Hiroshi, Silani, Vincenzo, Andrews, Jinsy A., Chen, Dafeng, Kulke, Sarah, Rudnicki, Stacy A., van den Berg, Leonard H.

“…Objective: To identify common practices of noninvasive ventilation (NIV) use among ALS specialists and how they follow respiratory status in their patients…”
Get full text

Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS by Gebrehiwet, Paulos, Meng, Lisa, Rudnicki, Stacy A, Sarocco, Phil, Wei, Jenny, Wolff, Andrew A, Butzner, Michael, Chiò, Adriano, Andrews, Jinsy A, Genge, Angela, Hughes, Dyfrig A, Jackson, Carlayne E, Lechtzin, Noah, Miller, Timothy M, Shefner, Jeremy M

“…To estimate the health utilities and quality-adjusted life years (QALYs) in patients with amyotrophic lateral sclerosis (ALS) receiving versus placebo in…”
Get more information

A rapidly progressing Pancoast syndrome due to pulmonary mucormycosis: a case report by Bansal, Meghana, Martin, Sara R, Rudnicki, Stacy A, Hiatt, Kim M, Mireles-Cabodevila, Eduardo

“…Pancoast syndrome is characterized by Horner syndrome, shoulder pain radiating down the arm, compression of the brachial blood vessels, and, in long-standing…”
Get full text

Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial by Rudnicki, Stacy A., Andrews, Jinsy A., Genge, Angela, Jackson, Carlayne, Lechtzin, Noah, Miller, Timothy M., Cockroft, Bettina M., Malik, Fady I., Meng, Lisa, Wei, Jenny, Wolff, Andrew A., Shefner, Jeremy M.

“…Objective: To evaluate the possible effect of reldesemtiv, a fast skeletal muscle troponin activator, on prescription and acceptance of durable medical…”
Get full text

Racial differences in motor neuron disease by Gundogdu, Betul, Al-Lahham, Tawfiq, Kadlubar, Fred, Spencer, Horace, Rudnicki, Stacy A.

“…Abstract Our objective was to compare and contrast clinical features of black and white patients seen in the UAMS ALS/Motor Neuron Disease (MND) clinic from…”
Get full text

Prevention and Treatment of Peripheral Neuropathy after Bariatric Surgery by Rudnicki, Stacy A.

“…Opinion statement Given the ever-increasing problem of obesity, it is not surprising that the number of patients who undergo bariatric surgery continues to…”
Get full text

Noninvasive ventilation use by patients enrolled in VITALITY-ALS by Rudnicki, Stacy A., Andrews, Jinsy A., Bian, Amy, Cockroft, Bettina M., Cudkowicz, Merit E., Hardiman, Orla, Malik, Fady I., Meng, Lisa, Wolff, Andrew A., Shefner, Jeremy M.

“…Objectives: To evaluate the prescribing practices of noninvasive ventilation (NIV) and patient compliance during VITALITY-ALS. Methods: VITALITY-ALS enrolled…”
Get full text

Lambert-Eaton myasthenic syndrome with pure ocular weakness by RUDNICKI, Stacy A

Get full text